Intravitreal Bevacizumab for Macular Edema Due to Central Retinal Vein Occlusion: Perfused vs. Ischemic and Early vs. Late Treatment

By DeCroos Francis Char   Ehlers Justis P.   Stinnett Sandra   Fekrat Sharon  

Current Eye Research, Vol. 36, Iss. 12, 2011-12 ,pp. : 1164-1170

Informa Healthcare

Access to resources Recommend Favorite

Intravitreal Bevacizumab Treatment for Macular Edema due to Branch Retinal Vein Occlusion in a Clinical Setting

By Siegel Ruth Axer   Dreznik Ayelet   Mimouni Karin   Bor Elite   Weinberger Dov   Bourla Dan Haim  

Current Eye Research, Vol. 37, Iss. 9, 2012-09 ,pp. : 823-829

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Bevacizumab and Triamcinolone for Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion – A Matched-Pairs Analysis

By  

Ophthalmologica, Vol. 224, Iss. 2, 2009-09 ,pp. : 126-132

Karger

Access to resources Recommend Favorite

Two-Year Results of Intravitreal Triamcinolone Acetonide Injection for the Treatment of Macular Edema Due to Central Retinal Vein Occlusion

By  

Annals of Ophthalmology, Vol. 39, Iss. 4, 2007-12 ,pp. : 307-312

Humana Press, Inc

Access to resources Recommend Favorite

1-year results of intravitreal aflibercept treatment for macular edema due to central retinal vein occlusion

By Stewart Michael W  

Expert Review of Ophthalmology, Vol. 8, Iss. 3, 2013-06 ,pp. : 241-244

Ashgate Publishing Ltd

Access to resources Recommend Favorite